Rare cytogenetic abnormalities in acute myeloid leukemia transformed from Fanconi anemia – a case report

BMC Research Notes

Salman Naseem Adil¹  Shabneez Hussain¹ 

[1] Section of Haematology, Department of Pathology and Microbiology, The Aga Khan University Hospital, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan

关键词: Cytogenetic abnormalities;    Acute myeloid leukemia;    Fanconi anemia;   

Others  :  1141944
DOI  :  10.1186/1756-0500-6-316

 received in 2013-05-09, accepted in 2013-07-22,  发布年份 2013

【 摘 要 】

Background

Fanconi’s anemia (FA) is an inherited bone marrow failure syndrome that carries a higher risk of transformation to acute myeloid leukemia (AML) when compared with general population. AML is the initial presentation in approximately one third of patients.

Case presentation

A 17 year old male presented to the emergency room with history of high grade fever since two weeks. Examination revealed pallor, short stature and thumb polydactyly. There was no visceromegaly or lymphadenopathy. Complete blood count showed haemoglobin 3.4 gm/dl, MCV 100 fl and MCH 36 pg, white blood cell count 55.9 × 10 E9/L and platelet count 8 × 10E9/L. Peripheral blood smear revealed 26% blast cells. Bone marrow was hypercellular exhibiting infiltration with 21% blast cells. Auer rods were seen in few blast cells. These findings were consistent with acute myelomonocytic leukemia. These blasts cells expressed CD33, CD13, HLA-DR, CD117, CD34 antigens and cytoplasmic myeloperoxidase on immunophenotyping. Bone marrow cytogenetics revealed 46, XY, t (8:21) (q22; q22) [11] / 46, XY, add (2) (q37), t (8; 21) [4] / 46, XY [5]. Molecular studies showed positivity of FLT 3 D835 variant and negativity of NPM 1 and FLT3 ITD (internal tandem domain) mutation. Peripheral blood analysis for chromosomal breakage exhibited tri-radial and complex figures. He received induction chemotherapy with cytarabine and daunorubicin (3 + 7). Day 14 marrow revealed clearance of blast cells.

Conclusion

The recognition of specific cytogenetic abnormalities present in FA known to predispose to AML is crucial for early haematopoietic stem cell transplant (HSCT) before transformation to leukemia.

【 授权许可】

   
2013 Hussain and Adil; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Rosenberg PS, Greene MH, Alter BP: Cancer incidence in persons with Fanconi anemia. Blood 2003, 101(3):822-826.
• [2]Shimamura A, Alter BP: Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 2010, 24(3):101-122.
• [3]Swift M: Fanconi's anaemia in the genetics of neoplasia. Nature 1971, 230(5293):370-373.
• [4]Mushtaq N, Wali R, Fadoo Z, Saleem AF: Acute lymphoblastic leukemia in a child with Fanconi's anaemia. J Coll Physicians Surg Pak 2012, 22(7):458-460.
• [5]Li X, Le Beau MM, Ciccone S, Yang FC, Freie B, Chen S, Yuan J, Hong P, Orazi A, Haneline LS, et al.: Ex vivo culture of Fancc−/− stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. Blood 2005, 105(9):3465-3471.
• [6]Alter BP: Fanconi's anemia and malignancies. Am J Hematol 1996, 53(2):99-110.
• [7]Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD: Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994, 84(5):1650-1655.
• [8]Alter BP: Cancer in Fanconi anemia, 1927–2001. Cancer 2003, 97(2):425-440.
• [9]Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr AG, Greene MH, Rosenberg PS: Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 2010, 150(2):179-188.
• [10]Rochowski A, Rosenberg PS, Alonzo TA, Gerbing RB, Lange BJ, Alter BP: Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy. Leuk Res 2012, 36(1):29-31.
• [11]Rochowski A, Olson SB, Alonzo TA, Gerbing RB, Lange BJ, Alter BP: Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer 2012, 59(5):922-924.
• [12]Mehta PA, Harris RE, Davies SM, Kim MO, Mueller R, Lampkin B, Mo J, Myers K, Smolarek TA: Numerical chromosomal changes and risk of development of myelodysplastic syndrome–acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 2010, 203(2):180-186.